Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Trials|January 21, 2022
The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30-33 weeks gestational age)Eleanor J Mitchell, Garry Meakin, Josie Anderson, et al.The New England Journal of Medicine|January 29, 2015
Less-tight versus tight control of hypertension in pregnancyLaura A Magee, Peter von Dadelszen, Evelyne Rey, et al.Acta Obstetricia Et Gynecologica Scandinavica|February 27, 2016
Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trialLaura A Magee, Peter von Dadelszen, Joel Singer, et al.Hypertension (Dallas, Tex. : 1979)|September 14, 2016
The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?Laura A Magee, Peter von Dadelszen, Joel Singer, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 26, 2016
Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study)Marianne Vidler, Laura A Magee, Peter von Dadelszen, et al.The Lancet. Child & Adolescent Health|October 20, 2025
Full exclusively enteral fluids from day 1 versus gradual feeding in preterm infants (FEED1): a open-label, parallel-group, multicentre, randomised, superiority trialShalini Ojha, Eleanor J Mitchell, Mark J Johnson, et al.American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consentLinda van Wyk, Kim E Boers, Sanne J Gordijn, et al.Archives of Disease in Childhood. Fetal and Neonatal Edition|December 21, 2025
Cost-consequence analysis of early full milk feeding versus gradual feeding with intravenous support in preterm infants: results from the FEED1 trialSeyran Naghdi, Shalini Ojha, Jon Dorling, et al.Lancet (London, England)|March 6, 2025
Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trialLarissa I van der Windt, Job Klumper, Ruben G Duijnhoven, et al.Hypertension (Dallas, Tex. : 1979)|August 24, 2016
The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial)Rashid J Ahmed, Amiram Gafni, Eileen K Hutton, et al.Pageof 15